Integrated Discovery-to-IND Platform
Advance in vivo CAR-T programs through a unified workflow spanning CAR discovery, pharmacology, plasmid DNA, antibody, RNA-tLNP, and tLVV development.
In Vivo CAR-T Solutions
In vivo CAR-T has the potential to eliminate the complexity of traditional ex vivo cell therapy, yet challenges in discovery, delivery, and CMC continue to slow development. ProBio's integrated platform combines discovery, pharmacology, plasmid, antibody, mRNA-tLNP, and targeted lentiviral vector expertise to accelerate programs from concept to clinic.
As in vivo CAR-T evolves from concept to clinical reality, developers need partners that understand both the science and the manufacturing requirements behind successful translation. ProBio offers a uniquely integrated ecosystem supporting every critical stage of development.
Backed by innovative delivery technologies, broad modality expertise, and a growing track record in in vivo CAR-T programs, we help transform promising ideas into clinically actionable therapies.
One-Stop In Vivo CAR-T Platform from Discovery to Clinical Readiness
Why ProBio
Innovative Delivery Technologies
Leverage proprietary platforms for targeted RNA-tLNP and lentiviral vector development, supported by advanced conjugation, analytical, and process-development expertise.
Accelerating Clinical Translation
Backed by 10+ successful in vivo CAR-T CMC project and 1 FDA IND clearance, ProBio helps developers move efficiently from early studies to IND-enabling development.
Applications and Use Cases
WEBINAR
Overcoming In Vivo CAR-T CMC Barriers
Explore key CMC challenges, market trends, and development strategies for in vivo CAR-T therapies.
WEBINAR
Industrializing In Vivo CAR-T
Learn how tLVV and RNA-tLNP platforms accelerate scalable in vivo CAR-T development.
WHITE
PAPER
Targeted LVV Design for In Vivo CAR-T
Discover design strategies for targeted lentiviral vectors, producer cells, and T-cell-specific delivery.
FLYER
BLA Service
Late Stage Process Development and Commercial Manufacturing Services.
Frequently Asked Questions
